FiercePharma

Affymetrix Launches Advanced RNA Amplification Technology for Whole-Genome Expression Analysis of FFPE Samples

Mindy Lee-Olsen, 408-731-5523 (Media)Vice President, Marketing ServicesorDoug Farrell, 408-731-5285 (Investors)Vice President, Investor Relations (NASDAQ:AFFX) announced today the availability of ...
CNBC

Affymetrix Delivers First Custom Axiom Array for Kaiser Permanente/UCSF Genotyping Project 6,000-Sample Pilot Studies Completed on Axiom Catalog Array With Superior Performance

SANTA CLARA, Calif., May 10, 2010 (BUSINESS WIRE) -- Affymetrix, Inc. (NASDAQ: AFFX) today announced that it has delivered the first custom array designed for a 100,000-sample genotyping project to be ...
Business Wire

Affymetrix Completes Acquisition of eBioscience Holding Company, Inc.

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix Inc., (NASDAQ:AFFX) today announced that the Company has completed its acquisition of eBioscience Holding Company, Inc., a privately-held company with ...
Nature

Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours

Whole-genome microarray gene expression profiling has rapidly become the gold standard platform for retrospective prognostic and predictive gene discovery in human cancers, but currently depends on ...
Nature

A robust plant RNA isolation method suitable for Affymetrix GeneChip analysis and quantitative real-time RT-PCR

Microarray analysis and quantitative real-time RT-PCR are the major high-throughput techniques that are used to study transcript profiles. One of the major limitations in these technologies is the ...
GEN

Affymetrix: More Than Microarrays

Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since ...